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While ankle arthrodesis was traditionally the gold standard method of treatment for disabling end-stage ankle arthritis, total ankle
replacement (TAR) has been an acceptable alternative. The satisfaction rate of patients with TAR however differs. The purpose of
our study is to investigate whether implant survival and results with special emphasis on the satisfaction rate of patients treated
with a TAR implanted by a single surgeon were comparable to the literature. This was a retrospective cohort study in a teaching
hospital. Data was collected from 52 patients who received a total ankle replacement (TAR) between 05/2002 and 06/2014. The
mean follow-up time was 4.2 years (95% CI 3.3 – 5.0). Results showed a high satisfaction rate of 94% and 94% survival of the TAR
after 5 years. We conclude that TAR with the Salto prosthesis is, in our hands, a reliable solution for end-stage ankle arthritis, with
results comparable to the literature.
1. Introduction
While ankle arthrodesis was traditionally the gold standard
method of treatment for disabling end-stage ankle arthri-
tis, total ankle replacement (TAR) has been an acceptable
alternative [1–4]. Drawbacks of ankle fusion are nonunion,
quite long postoperative immobilization, and in the long-
term arthritis in the adjacent joints [5, 6]. Disadvantages of
TAR are the technical difficulty of the procedure, causing a
considerable learning curve [7–9] and uncertain long-term
survival of the implant [3, 10, 11]. The satisfaction rate of
patients with TAR also differs. Conflicting reports exist about
the cause for this difference in satisfaction. Spirt et al. [12] and
Henricson et al. [13] found a worse result in younger patients,
focusing on implant survival, complication rates, and revision
rates. Tenenbaum et al. [14] and Dematracopoulous et al. [15]
reported equal results in different age groups, considering
clinical outcomes, gait improvement, and patient reported
outcome. Schenk et al. [16] reported 6.9%unsatisfied patients,
mostly because of conversion of the prosthesis to an arthrode-
sis. Other factors influencing implant survival, and with that
patient satisfaction, are preoperative alignment, body weight,
and proper operative technique. Furthermore, management
of the expectations of the patients and explicit information in
the preoperative phase is of influence [17].The purpose of our
study is to investigate whether implant survival and results
with special emphasis on the satisfaction rate of our patients
treated with a TAR were comparable to the literature.
2. Patients and Methods
2.1. Study Design and Setting. This was a retrospective cohort
study. Data was collected from patients who received a total
ankle replacement (TAR) between 05/2002 and 06/2014 in the
HAGAHospital, the Hague, in the Netherlands. All surgeries
were performed by the same Orthopedic Surgeon specialized
in foot and ankle surgery (FF). The study was enlisted by the
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Medical Ethical Committee Southwest Holland (15-103) and
was declared not to subdue to Medical Research Involving
Human Subjects Act. The board of directors of the hospital
approved the study.
2.2. Participants. Patientswho received aTAR in the previous
mentioned time window were included in the study. Patients
with the following criteria were included: symptomatic ankle
osteoarthritis (Kellgren-lawrence score of 3+ or 4 despite
conservative treatment), age≥ 65 years (except rheumatoid
patients), BMI ≤ 30, American Society of Anesthesiolo-
gists (ASA) stage 1, 2, or 3, adequate bone-quality, ≤10∘
varus or valgus deformity, and no (extreme) sport wish.
Exclusion criteria for a TAR were neurological disorders,
bad peripheral circulation, osteonecrosis of talus or tibia,
and infection present. The operation was performed under
spinal or general anesthesia. Half an hour prior to surgery
and 24 hours postoperatively intravenous antibiotics were
administered. Standard anterior approach was used and an
uncemented SALTO prosthesis (Tornier SA, Saint Ismier,
France)was placed (a third-generation ankle prosthesis, three
components, and mobile bearing). Postoperative treatment
consisted of a lower leg cast: first 2 weeks non-weight-
bearing followed by 2 weeks full-weight-bearing. After cast
removal, an intensive physical therapy program was followed
for at least 6 weeks. The questionnaires were distributed
with a minimum of 1 year follow-up and the postoperative
X-rays were made the first day after surgery and 4 weeks
postoperatively. The follow-up X-rays were performed with
AP and lateral weight-bearing X-rays on a 2-yearly routine
base.
2.3. Variables. Patients’ satisfaction was measured by asking
one question: “would you choose the TAR again in a similar
situation?”
Revision of the TAR was defined as any secondary
operation in which a prosthetic component was exchanged
and/or conversion to an arthrodesis had to be performed, for
any reason.
Functional outcome was measured by the Foot Function
Index (FFI) [18]. We used the validated Dutch Version using
verbal rating scales provided by Kuyvenhoven et al. [19].
The second outcomemeasurewas theAmericanOrthopaedic
Foot and Ankle Society (AOFAS) questionnaire [20].
2.4. Measurement. Radiological outcome for the position
of the prosthesis components is measured in degrees on
first weight-bearing postoperative X-ray compared to last
postoperative X-ray (Figure 1). Measurements, calculated
as angular deviation according to the perfect position, are
performed as described by Valderrabano et al. [21].
Radiographic analysis were performed by one indepen-
dent senior orthopaedic surgeon (SvVK).
2.5. Statistical Methods. Continuous baseline characteris-
tics were presented as mean with 95% confidence interval
between square brackets. Nominal data was presented in
counts and percentages. Statistical analyses were conducted
Figure 1: Radiological angles. Perfect tibial position is defined as
𝛾 angle 90 degrees and in the sagittal plane position of the tibial
component with an inclination till 7 degrees (𝛼 = +7; according to
the manufacturer of the Salto prosthesis). Perfect talar position is
placement of this component parallel to the sole of the foot (𝛽 angle
0 degrees). An angle-difference over time of 5 degrees or more is
considered significant and is classified as migration. Malposition is
defined as an angulation of a component of more than 10 degrees
from the perfect position as defined by Schimmel [7].
in SPSS version 17 (IBM Co., Armonk, NY, USA). For all
statistical analyses, a two-tailed p-value less than 0.05 was
considered to be statistically significant.
Patient satisfaction was presented in percentages. A
Kaplan-Meier curve was presented for survival analysis with
revision for any reason as endpoint. All functional outcomes
were presented as mean with 95% confidence interval (CI)
and the radiological outcomes as median and IQR.
3. Results
3.1. Participants. A total 52 patients were included in the
study. The mean follow-up time was 4.2 years (95% CI 3.3 –
5.0, range 0.1 – 13.7).
All baseline characteristics are presented in Table 1.
3.2. Outcome. In total 48 of the 51 patients would choose
the TAR again in a similar situation (94% satisfaction rate).
One answer was missing, because we were unable to contact
this patient. Two patients were dissatisfied with the TAR;
one patient required a conversion to an arthrodesis for septic
loosening and the other dissatisfied patient had persistent
pain, but had good function and perfect radiological images.
This TARwas converted to an ankle arthrodesis for suspicion
of low grade infection, which was not confirmed. Pain
persisted even after an uneventful solid ankle fusion with
allograft.
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Table 1: Baseline characteristics.
Age, mean Years, range 70 [49 – 86]
Gender Male 26 [50%]
Female 26 [50%]
Side Left 19 [64%]
Right 33 [37%]
ASA 1 21 [40%]
2 26 [50%]
3 2 [4%]
Missing 3 [6%]
Smoking No 44 [85%]
Yes 7 [14%]
Missing 1 [2%]
Indication Post-traumatic 29 [56%]
Primary Osteoarthritis 18 [35%]
Rheumatoid Arthritis 4 [8%]
Rheumatoid Arthritis and Post-traumatic 1 [2%]
Censored
Survival Function
0,0
0,2
0,4
0,6
0,8
1,0
Cu
m
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1,00 2,00 3,00 4,00 5,00,00
Follow up in years
Figure 2: Survival of the TAR in years. At 2,5 years 29 were at risk
and at 5 years 15 were at risk. The overall survival time is 11 with a
95% confidence interval of 10-13.
Three of all patients had an ankle arthrodesis on the
contralateral side.These patients all preferred their TAR over
their ankle arthrodesis.
In Figure 2 the Kaplan-Meier curve is presented. The
survival of the TAR after 5 years is 94% with 15 patients at
risk.
The functional and radiological results are presented
in Table 2. The mean total AOFAS score was 85 out of a
maximum of 100 points. The mean total FFI was 36 out of
a maximum of 115 (with 23 as lowest and best score).
Not for all the 52 patients clinical and radiological data
could be collected. The patients that were converted to an
arthrodesis were excluded. In addition, we were unable to
reach one patient (likementioned above) and one patient was
not willing to come to the hospital and only answered the
satisfaction question on the phone.This explains the different
numbers in the first column.
3.3. Complications. Five talar component malpositions were
noted at postoperative weight-bearing X-rays. Four malpo-
sitions of the tibial part were discovered, of which one was
treated with a reoperation within two weeks: repositioning
of the tibial component leading to a satisfactory result
afterwards. Preoperatively, 2 medial malleolus fractures and
1 lateral malleolus fracture occurred. All fractures were fixed
during the ankle replacement procedure.
Three patients suffered from prolonged wound healing:
more than 4 weeks postoperatively wound leakage was
present: these all resolvedwith prolonged immobilization and
antibiotics.
During the follow-up period in 4 cases, conversion to an
arthrodesis was necessary. Two patients needed conversion
because of aseptic loosening caused by multiple cysts; one
patient suffered from severe wound problems and an acute
deep infection. One conversion was performed because of
persistent pain and suspicion of low grade infection, which
was not confirmed during reoperation.
4. Discussion
TAR is known as a technically demanding procedure and a
considerable learning curve is described by several authors
[7–9]. Yet, equally functional results are described by Reuver
et al. [22] in low volume centres: the AOFAS score of these
authors had an average of 75 (SD ± 15). Our study, single
surgeon and low volume, shows an even higher average
AOFAS score of 85 (SD ± 17). This difference could be
explained because the senior author of this series (FF)
already had considerable experience in TAR with another
type ankle prosthesis (STAR) before he started implanting
the Salto prosthesis. The functional outcome of this study is
comparable to other series that also described the FFI and/or
the AOFAS score as an outcome parameter.The FFI found by
Kerkhoff et al. [23] and Schimmel et al. [7] were 33 and 32,
respectively. The AOFAS score varied from 73 to 85 [16, 24–
27]. Bonnin, who is actually one of the inventers of the Salto
prosthesis, described an AOFAS score of 79 points, with a
follow-up of 7–11 years [28]. So, in our hands, the functional
results are certainly not inferior.
In our study 48 of the 51 patients (94%) would have the
TAR performed again in a similar situation, of whom some
are even revised and converted to an arthrodesis. Yet, 2 of
the 2 dissatisfied patients had a revision. So implant survival
and satisfaction are definitely related. Implant survival can
be improved by proper technique, for instance, component
placement in proper alignment [3, 29]. Our survival rate is
94% after 5 years with 15 patients at risk. This is better than
the results described by Henricsson et al. [13], that is, 78%
survival at 5 years. One study found a 94% implant survival
at 5 years, even 87% survival at 10 years, which dropped quite
steep to 64% after 15 years [30]. One of our exclusion criteria
for a TAR is age: we excluded patients younger than 65 years,
in whom we prefer an arthrodesis, except for rheumatoid
patients. These patients often have other joint impairments
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Table 2
N Range
FFI Activity 45 Mean [95% CI] 18 [16 -20] [9-43]
Pain 45 Mean [95% CI] 16 [14 – 18] [9-39]
Restriction 45 Mean [95% CI] 8 [7 -9] [5-16]
Total 45 Mean [95% CI] 42 [37 – 47] [25-94]
AOFAS Alignment 45 Mean [95% CI] 9 [8 – 10] [0-10]
Function 45 Mean [95% CI] 41 [38 – 45] [5-50]
Pain 45 Mean [95% CI] 34 [32 – 37] [20-40]
Total 45 Mean [95% CI] 85 [80 – 90] [26-100]
Radiological outcome First alpha 49 Median [IQR] 6 [4] [ -3 - 12]
Last alpha 47 Median [IQR] 5 [4] [-3-14]
First beta 49 Median [IQR] -4 [8] [-15-9]
Last beta 47 Median [IQR] -4 [9] [-15-8]
First gamma 49 Median [IQR] 0 [2] [-4-5]
Last gamma 47 Median [IQR] 0 [4] [-5-7]
(hindfoot, midfoot), which probably benefit when the ankle
joint is kept mobile instead of fused. Gait analysis showed a
more normal gait in TARpatients than in patients who had an
arthrodesis [31]. Although the age selection criterion seems
justifiable in terms of long-term implant survival, reports in
the literature are conflicting. Kofoed and Lundberg-Jensen
[32] and Skytta¨ et al. [33] described no influence of age;
Tenenbaumet al. [14] reported equal functional improvement
in patients over 70 years patients and aged 50-60 years. In
contrast with this, Henricson et al. [13] and Raikin et al. [34]
all reported worse results in younger patients. Because of our
high patient satisfaction and the good survival rate compared
with the literature, we consider performing TARs in younger
patients. We realize we have to inform this younger group
about the risk of a conversion to an arthrodesis later in life.
The strong points of this study were the independent
investigators who performed the patient investigations at
follow-up, the high follow-up percentage, and the use of one
and the same prosthesis, with an unchanged design by the
same surgeon. A weak point is its retrospective design, so no
preoperative clinical scores were available.
5. Conclusion
We conclude that TAR with the Salto prosthesis is, in our
hands, a reliable solution for end-stage ankle arthritis, with
results comparable to the literature.
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